iSpecimen preannounces Q3 revenue $2.6-$2.8M, up 60-70% sequentially

iSpecimen Inc.

2023-Q3 EPS reported -$0.89 revenue$7,353,090

Preliminary Q3 2023 revenue expected between $2.6M and $2.8M, vs Q2 2023 revenue of $1.63M.
Next-day quote program drove 122% increase in quote-to-purchase order conversion vs prior four-quarter average.
Company cites operational improvements and line-of-business restructuring as additional growth drivers.
Conference call to discuss Q3 results scheduled for November 2, 2023 at 8:30 a.m. ET.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

iSpecimen Inc. reported the quarter ended September 30, 2023 results: revenue $2.6 to $2.8 million.

Period: the quarter ended September 30, 2023
Revenue: $2.6 to $2.8 million
Result: preliminary results

Exact text from the filing

The Company expects third quarter 2023 revenue to be between $2.6 to $2.8 million, representing an increase of between 60% to 70% from second quarter 2023 revenue of $1.63 million.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-110650

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.